FEBU
Fellow of the European Board of Urology
Localized Prostate CancerEnglish
Exam overviewPractice session
A 66-year-old man is diagnosed with cT1c prostate adenocarcinoma, ISUP Grade Group 1, PSA 6.2 ng/mL, PSA density 0.09 ng/mL/cc, and two short positive cores. MRI shows no extracapsular extension. He is anxious about urinary and sexual adverse effects. Which initial management is most guideline-consistent?
Loading your practice session…